DLL3 and small cell lung carcinoma: One particularly promising avenue of research focuses on Delta-like ligand 3 (DLL3), a protein integral to the Notch signaling pathway that exhibits significant overexpression in specific SCLC subtypes, particularly those with pronounced neuroendocrine characteristics (18, 19).